Eterna Therapeutics Statistics
Total Valuation
ERNA has a market cap or net worth of $11.63 million. The enterprise value is $49.87 million.
| Market Cap | 11.63M |
| Enterprise Value | 49.87M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, after market close.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ERNA has 5.41 million shares outstanding. The number of shares has increased by 5.52% in one year.
| Shares Outstanding | 5.41M |
| Shares Change (YoY) | +5.52% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 39.31% |
| Owned by Institutions (%) | 7.56% |
| Float | 2.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 101.15 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 433.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.79
| Current Ratio | 0.79 |
| Quick Ratio | 1.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.36 |
Financial Efficiency
Return on equity (ROE) is -1,466.80% and return on invested capital (ROIC) is -49.82%.
| Return on Equity (ROE) | -1,466.80% |
| Return on Assets (ROA) | -46.30% |
| Return on Capital (ROIC) | -49.82% |
| Revenue Per Employee | $14,375 |
| Profits Per Employee | -$2.86M |
| Employee Count | 8 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.24% in the last 52 weeks. The beta is 7.89, so ERNA's price volatility has been higher than the market average.
| Beta (5Y) | 7.89 |
| 52-Week Price Change | -27.24% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 62.64 |
| Average Volume (20 Days) | 8,603 |
Short Selling Information
The latest short interest is 54,500, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 54,500 |
| Short Previous Month | 54,951 |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.84% |
| Short Ratio (days to cover) | 9.49 |
Income Statement
In the last 12 months, ERNA had revenue of $115,000 and -$22.92 million in losses. Loss per share was -$4.25.
| Revenue | 115,000 |
| Gross Profit | -132,000 |
| Operating Income | -21.94M |
| Pretax Income | -22.90M |
| Net Income | -22.92M |
| EBITDA | -19.90M |
| EBIT | -21.50M |
| Loss Per Share | -$4.25 |
Balance Sheet
The company has $9.21 million in cash and $47.45 million in debt, giving a net cash position of -$38.24 million or -$7.07 per share.
| Cash & Cash Equivalents | 9.21M |
| Total Debt | 47.45M |
| Net Cash | -38.24M |
| Net Cash Per Share | -$7.07 |
| Equity (Book Value) | -3.41M |
| Book Value Per Share | -0.63 |
| Working Capital | -1.60M |
Cash Flow
In the last 12 months, operating cash flow was -$18.11 million and capital expenditures -$116,000, giving a free cash flow of -$18.22 million.
| Operating Cash Flow | -18.11M |
| Capital Expenditures | -116,000 |
| Free Cash Flow | -18.22M |
| FCF Per Share | -$3.37 |
Margins
Gross margin is -114.78%, with operating and profit margins of -19,078.26% and -19,926.09%.
| Gross Margin | -114.78% |
| Operating Margin | -19,078.26% |
| Pretax Margin | -19,915.65% |
| Profit Margin | -19,926.09% |
| EBITDA Margin | -17,305.22% |
| EBIT Margin | -18,698.26% |
| FCF Margin | -15,845.22% |
Dividends & Yields
ERNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.52% |
| Shareholder Yield | -5.52% |
| Earnings Yield | -197.00% |
| FCF Yield | -156.65% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 17, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 17, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
ERNA has an Altman Z-Score of -6.79 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.79 |
| Piotroski F-Score | 1 |